Learn more about the role of Tuberculosis in cancer and how a simple vaccine supports the immune system to fight it.

BLADDER cancer is classified as either non-muscle invasive bladder cancer (NMIBC) or muscle-invasive bladder cancer (MIBC) based on the American Joint Committee on Cancer (AJCC) TNM staging. At ...

Cretostimogene treatment shows best-in-class durability of response for BCG-unresponsive non-muscle invasive bladder cancer ...

RAG-01 is an innovative saRNA therapy designed to upregulate the p21 tumor suppressor gene, a key regulator of cell cycle progression that has been challenging to target with traditional therapies.

Today, the conventional treatment for non-invasive bladder cancer is immunotherapy with BCG (Bacillus Calmette-Guérin), a weakened bacterium that is introduced into the bladder to stimulate an ...

Immunotherapy. 2012;4(6):629-647. Conventional antibiotic therapy of TB requires prolonged treatment. It is subject to compliance issues, rising rates of antibiotic resistance and frequent ...

CULVER CITY, Calif., March 13, 2025--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced U.S. Urology Partners, one of the nation’s ...